{{Rsnum
|rsid=3096299
|Gene=ANKRD11
|Chromosome=16
|position=89382255
|Orientation=minus
|GMAF=0.4467
|Gene_s=ANKRD11
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 48.7 | 31.9
| HCB | 22.6 | 52.6 | 24.8
| JPT | 11.5 | 44.2 | 44.2
| YRI | 25.2 | 49.7 | 25.2
| ASW | 22.8 | 49.1 | 28.1
| CHB | 22.6 | 52.6 | 24.8
| CHD | 22.0 | 36.7 | 41.3
| GIH | 29.0 | 43.0 | 28.0
| LWK | 24.5 | 50.9 | 24.5
| MEX | 29.3 | 51.7 | 19.0
| MKK | 29.5 | 39.7 | 30.8
| TSI | 13.7 | 43.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (IgH translocation)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=G
  |Pval=4E-6
  |OR=1.54
  |ORtxt=[1.28-1.86]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}